Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 131611 - 131620 of 132111 results

First page
Previous page
Next page
Next page

ALCOHOL 95%

7528N5H79B

Status:

Possibly Marketed Outside US

Source:

21 CFR 348

(2022)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dfdafc2d-ffbc-8de6-e053-2995a90aef3d

First approved in 2010

Source:

M032

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=939f90e7-e1de-4ca3-a484-90f1b87797d6

Class:

G1 SPECIFIED SUBSTANCE

DIMETHICONE/PEG-10/15 CROSSPOLYMER IN DIMETHICONE 6 (130000 CPS)

N4333D0ELC

Status:

Possibly Marketed Outside US

Source:

M020

(2010)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2035ab03-80b4-49f4-b379-eb8bc42c9cee

First approved in 2010

Source:

M020

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2035ab03-80b4-49f4-b379-eb8bc42c9cee

Class:

G1 SPECIFIED SUBSTANCE

PLASACRYL T20

U3HKX3SA66

Status:

Possibly Marketed Outside US

Source:

ANDA217738

(2010)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=167340c2-1234-4d00-b4e2-cccf3d270fda

First approved in 2010

Source:

ANDA217738

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=167340c2-1234-4d00-b4e2-cccf3d270fda

Class:

G1 SPECIFIED SUBSTANCE

GLYCERYL STEARATE/PEG-100 STEARATE

RD25J5V947

Status:

Possibly Marketed Outside US

Source:

ANDA205249

(2020)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d01b8f72-c2d2-49d8-87d7-3d60f11a7bbb

First approved in 2010

Source:

21 CFR 333D

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e068b0bf-30bd-6c87-e053-2995a90ac47d

Class:

G1 SPECIFIED SUBSTANCE

FRAGRANCE LEMON ORC2001060

K1725A7G95

Status:

Possibly Marketed Outside US

Source:

21 CFR 333A

(2009)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0c6e7897-205c-4f79-bf6d-3df16a878164

First approved in 2009

Source:

21 CFR 333A

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0c6e7897-205c-4f79-bf6d-3df16a878164

Class:

G1 SPECIFIED SUBSTANCE

NONCRYSTALLIZING SORBITOL SOLUTION

9E0S3UM200

Status:

Possibly Marketed Outside US

Source:

ANDA209224

(2008)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=614490ce-a62c-4222-8e4b-ce802cf63028

First approved in 2008

Source:

ANDA209224

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=614490ce-a62c-4222-8e4b-ce802cf63028

Class:

G1 SPECIFIED SUBSTANCE

MICROCRYSTALLINE CELLULOSE 302

91B875MM4H

Status:

Possibly Marketed Outside US

Source:

ANDA214473

(2023)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=034bcbad-f57f-4338-a193-7a5aa9f09aa6

First approved in 2006

Source:

ANDA217151

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fdb36cfa-d20a-4fd9-b994-a5d16e4bb438

Class:

G1 SPECIFIED SUBSTANCE

ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B

HZJ2V81RYU

Status:

Possibly Marketed Outside US

Source:

ANDA213985

(2003)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0c7fd6ab-2ce5-4110-b6e6-9103c8da0765

First approved in 2003

Source:

ANDA213985

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0c7fd6ab-2ce5-4110-b6e6-9103c8da0765

Class:

G1 SPECIFIED SUBSTANCE

MICROCRYSTALLINE CELLULOSE 200

5XDI2TS1EZ

Status:

Possibly Marketed Outside US

Source:

ANDA076577

(2003)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=32fad00b-7e7b-4d35-9e8b-fdc979fdb88e

First approved in 2003

Source:

ANDA076577

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=32fad00b-7e7b-4d35-9e8b-fdc979fdb88e

Class:

G1 SPECIFIED SUBSTANCE

MICROCRYSTALLINE CELLULOSE 301

W7YXH6D4BD

Status:

Possibly Marketed Outside US

Source:

ANDA079188

(2003)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cdfb7868-3eba-46e1-a286-ca40760fd98d

First approved in 2003

Source:

ANDA079188

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cdfb7868-3eba-46e1-a286-ca40760fd98d

Class:

G1 SPECIFIED SUBSTANCE

Concept

ALCOHOL 95%

Concept

DIMETHICONE/PEG-10/15 CROSSPOLYMER IN DIMETHICONE 6 (130000 CPS)

Concept

Concept

GLYCERYL STEARATE/PEG-100 STEARATE

Concept

FRAGRANCE LEMON ORC2001060

Concept

NONCRYSTALLIZING SORBITOL SOLUTION

Concept

MICROCRYSTALLINE CELLULOSE 302

Concept

ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B

Concept

MICROCRYSTALLINE CELLULOSE 200

Concept

MICROCRYSTALLINE CELLULOSE 301

Showing 131611 - 131620 of 132111 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1